Literature DB >> 8339621

Pneumocystis carinii pneumonia in patients without predisposing illnesses. Acute episode and follow-up of five cases.

S Cano1, F Capote, A Pereira, E Calderon, J Castillo.   

Abstract

Pneumocystis carinii pneumonia (PCP) is described almost exclusively in immunocompromised hosts. This report describes our experience with acute episodes and the follow-up of five patients with PCP who had no known predisposing conditions. The average follow-up period was 3.6 years (range, 2.6 to 4 years). Lymphocyte subpopulations (CD4, CD8, and CD4:CD8), serum immunoglobulins (IgG, IgM, and IgA), and serologic studies for human immunodeficiency virus were carried out on all patients at least twice, both at the beginning and the end of the follow-up. None of the patients presented compatible data with AIDS or any other identifiable risk factors. We conclude that PCP can occur in patients who apparently do not have immunosuppression.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8339621     DOI: 10.1378/chest.104.2.376

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  10 in total

Review 1.  Cavitary pulmonary disease.

Authors:  L Beth Gadkowski; Jason E Stout
Journal:  Clin Microbiol Rev       Date:  2008-04       Impact factor: 26.132

Review 2.  AIDS and the lung: update 1995. 1. Pneumocystis carinii pneumonia.

Authors:  R F Miller; D M Mitchell
Journal:  Thorax       Date:  1995-02       Impact factor: 9.139

Review 3.  Bronchoscopic diagnosis of pneumonia.

Authors:  V S Baselski; R G Wunderink
Journal:  Clin Microbiol Rev       Date:  1994-10       Impact factor: 26.132

4.  Possible Diagnostic Delays and Missed Prevention Opportunities in Pneumocystis Pneumonia Patients Without HIV: Analysis of Commercial Insurance Claims Data-United States, 2011-2015.

Authors:  Jeremy A W Gold; Brendan R Jackson; Kaitlin Benedict
Journal:  Open Forum Infect Dis       Date:  2020-06-29       Impact factor: 3.835

5.  Pneumocystis pneumonia in an immunocompetent patient developing a subacute disease course with central consolidation.

Authors:  Chiaki Kawame; Hidehiro Yokota; Kohei Shikano; Hajime Kasai; Masaki Suzuki; Mitsuhiro Abe; Takashi Kishimoto; Jun-Ichiro Ikeda; Seiichiro Sakao; Takuji Suzuki
Journal:  Respir Med Case Rep       Date:  2022-05-01

Review 6.  Pneumocystis jirovecii colonization in chronic pulmonary disease.

Authors:  S Gutiérrez; N Respaldiza; E Campano; M T Martínez-Risquez; E J Calderón; C De La Horra
Journal:  Parasite       Date:  2011-05       Impact factor: 3.000

7.  Granulomatous PJP presenting as a solitary lung nodule in an immune competent female.

Authors:  J Lam; M M Kelly; R Leigh; M D Parkins
Journal:  Respir Med Case Rep       Date:  2013-10-26

8.  Clinical characteristics and prognosis of patients with Pneumocystis jirovecii pneumonia without a compromised illness.

Authors:  Tae-Ok Kim; Jae-Kyeong Lee; Yong-Soo Kwon; Yu-Il Kim; Sung-Chul Lim; Min-Seok Kim; Bo Gun Kho; Cheol-Kyu Park; In-Jae Oh; Young-Chul Kim; Ha Young Park; Hong-Joon Shin
Journal:  PLoS One       Date:  2021-02-04       Impact factor: 3.240

Review 9.  Increased susceptibility to pneumonia due to tumour necrosis factor inhibition and prospective immune system rescue via immunotherapy.

Authors:  Ryan Ha; Yoav Keynan; Zulma Vanessa Rueda
Journal:  Front Cell Infect Microbiol       Date:  2022-09-07       Impact factor: 6.073

10.  Pneumocystis Jiroveci Pneumonia and Newly Diagnosed Human Immunodeficiency Virus (AIDS) in a 63-Year-Old Woman.

Authors:  Wissam Sabbagh; Noor S Darwich
Journal:  Am J Case Rep       Date:  2018-08-08
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.